Cambridge Cognition Holdings plc announced that Dr. Andy Blackwell will step down as an Executive Director but will remain on the Board as a Non-Executive Director with effect from the 1 July 2015. Andy joined the company in 2006 and was appointed as a Director and CSO in 2007. Andy helped the company list on AIM in April 2013 and assisted in the completion of the new strategic plan which is now being implemented.

Andy has led the scientific commercial development activities and built the scientific team that has established Cantab as the number one in computerised cognition technology. In his role as NED Andy will continue to support the company's world-class scientific teams in the EU and USA. As a result of this change Andy will be able to pursue other opportunities and at the same time, the company will still benefit from the key relationships Andy holds with the scientific and technology community, industry partners and patient advocacy groups.